“Some days I get up and will’t think how significantly we’ve come,” said Dr. Doblin, 67, who now oversees the Multidisciplinary Association for Psychedelic Scientific tests, a multimillion dollar analysis and advocacy empire that employs one hundred thirty neuroscientists, pharmacologists and regulatory experts Operating to put the groundwo